Request for Covid-19 Impact Assessment of this Report
The United States 20s Proteasome market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global 20s Proteasome market, reaching US$ million by the year 2028. As for the Europe 20s Proteasome landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main 20s Proteasome players cover Amgen Inc, Celgene Corp, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of 20s Proteasome market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Marizomib
Oprozomib
Carfilzomib
VPEA-002
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Colon Cancer
Lymphoma
Malignant Glioma
Neuroendocrine Cancer
Ovarian Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Amgen Inc
Celgene Corp
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global 20s Proteasome Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for 20s Proteasome by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for 20s Proteasome by Country/Region, 2017, 2022 & 2028
2.2 20s Proteasome Segment by Type
2.2.1 Marizomib
2.2.2 Oprozomib
2.2.3 Carfilzomib
2.2.4 VPEA-002
2.2.5 Others
2.3 20s Proteasome Sales by Type
2.3.1 Global 20s Proteasome Sales Market Share by Type (2017-2022)
2.3.2 Global 20s Proteasome Revenue and Market Share by Type (2017-2022)
2.3.3 Global 20s Proteasome Sale Price by Type (2017-2022)
2.4 20s Proteasome Segment by Application
2.4.1 Colon Cancer
2.4.2 Lymphoma
2.4.3 Malignant Glioma
2.4.4 Neuroendocrine Cancer
2.4.5 Ovarian Cancer
2.4.6 Others
2.5 20s Proteasome Sales by Application
2.5.1 Global 20s Proteasome Sale Market Share by Application (2017-2022)
2.5.2 Global 20s Proteasome Revenue and Market Share by Application (2017-2022)
2.5.3 Global 20s Proteasome Sale Price by Application (2017-2022)
3 Global 20s Proteasome by Company
3.1 Global 20s Proteasome Breakdown Data by Company
3.1.1 Global 20s Proteasome Annual Sales by Company (2020-2022)
3.1.2 Global 20s Proteasome Sales Market Share by Company (2020-2022)
3.2 Global 20s Proteasome Annual Revenue by Company (2020-2022)
3.2.1 Global 20s Proteasome Revenue by Company (2020-2022)
3.2.2 Global 20s Proteasome Revenue Market Share by Company (2020-2022)
3.3 Global 20s Proteasome Sale Price by Company
3.4 Key Manufacturers 20s Proteasome Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 20s Proteasome Product Location Distribution
3.4.2 Players 20s Proteasome Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for 20s Proteasome by Geographic Region
4.1 World Historic 20s Proteasome Market Size by Geographic Region (2017-2022)
4.1.1 Global 20s Proteasome Annual Sales by Geographic Region (2017-2022)
4.1.2 Global 20s Proteasome Annual Revenue by Geographic Region
4.2 World Historic 20s Proteasome Market Size by Country/Region (2017-2022)
4.2.1 Global 20s Proteasome Annual Sales by Country/Region (2017-2022)
4.2.2 Global 20s Proteasome Annual Revenue by Country/Region
4.3 Americas 20s Proteasome Sales Growth
4.4 APAC 20s Proteasome Sales Growth
4.5 Europe 20s Proteasome Sales Growth
4.6 Middle East & Africa 20s Proteasome Sales Growth
5 Americas
5.1 Americas 20s Proteasome Sales by Country
5.1.1 Americas 20s Proteasome Sales by Country (2017-2022)
5.1.2 Americas 20s Proteasome Revenue by Country (2017-2022)
5.2 Americas 20s Proteasome Sales by Type
5.3 Americas 20s Proteasome Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 20s Proteasome Sales by Region
6.1.1 APAC 20s Proteasome Sales by Region (2017-2022)
6.1.2 APAC 20s Proteasome Revenue by Region (2017-2022)
6.2 APAC 20s Proteasome Sales by Type
6.3 APAC 20s Proteasome Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe 20s Proteasome by Country
7.1.1 Europe 20s Proteasome Sales by Country (2017-2022)
7.1.2 Europe 20s Proteasome Revenue by Country (2017-2022)
7.2 Europe 20s Proteasome Sales by Type
7.3 Europe 20s Proteasome Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa 20s Proteasome by Country
8.1.1 Middle East & Africa 20s Proteasome Sales by Country (2017-2022)
8.1.2 Middle East & Africa 20s Proteasome Revenue by Country (2017-2022)
8.2 Middle East & Africa 20s Proteasome Sales by Type
8.3 Middle East & Africa 20s Proteasome Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 20s Proteasome
10.3 Manufacturing Process Analysis of 20s Proteasome
10.4 Industry Chain Structure of 20s Proteasome
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 20s Proteasome Distributors
11.3 20s Proteasome Customer
12 World Forecast Review for 20s Proteasome by Geographic Region
12.1 Global 20s Proteasome Market Size Forecast by Region
12.1.1 Global 20s Proteasome Forecast by Region (2023-2028)
12.1.2 Global 20s Proteasome Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global 20s Proteasome Forecast by Type
12.7 Global 20s Proteasome Forecast by Application
13 Key Players Analysis
13.1 Amgen Inc
13.1.1 Amgen Inc Company Information
13.1.2 Amgen Inc 20s Proteasome Product Offered
13.1.3 Amgen Inc 20s Proteasome Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Amgen Inc Main Business Overview
13.1.5 Amgen Inc Latest Developments
14 Research Findings and Conclusion
Table 1. 20s Proteasome Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. 20s Proteasome Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Marizomib
Table 4. Major Players of Oprozomib
Table 5. Major Players of Carfilzomib
Table 6. Major Players of VPEA-002
Table 7. Major Players of Others
Table 8. Global 20s Proteasome Sales by Type (2017-2022) & (K Pcs)
Table 9. Global 20s Proteasome Sales Market Share by Type (2017-2022)
Table 10. Global 20s Proteasome Revenue by Type (2017-2022) & ($ million)
Table 11. Global 20s Proteasome Revenue Market Share by Type (2017-2022)
Table 12. Global 20s Proteasome Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global 20s Proteasome Sales by Application (2017-2022) & (K Pcs)
Table 14. Global 20s Proteasome Sales Market Share by Application (2017-2022)
Table 15. Global 20s Proteasome Revenue by Application (2017-2022)
Table 16. Global 20s Proteasome Revenue Market Share by Application (2017-2022)
Table 17. Global 20s Proteasome Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global 20s Proteasome Sales by Company (2020-2022) & (K Pcs)
Table 19. Global 20s Proteasome Sales Market Share by Company (2020-2022)
Table 20. Global 20s Proteasome Revenue by Company (2020-2022) ($ Millions)
Table 21. Global 20s Proteasome Revenue Market Share by Company (2020-2022)
Table 22. Global 20s Proteasome Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers 20s Proteasome Producing Area Distribution and Sales Area
Table 24. Players 20s Proteasome Products Offered
Table 25. 20s Proteasome Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global 20s Proteasome Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global 20s Proteasome Sales Market Share Geographic Region (2017-2022)
Table 30. Global 20s Proteasome Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global 20s Proteasome Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global 20s Proteasome Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global 20s Proteasome Sales Market Share by Country/Region (2017-2022)
Table 34. Global 20s Proteasome Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global 20s Proteasome Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas 20s Proteasome Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas 20s Proteasome Sales Market Share by Country (2017-2022)
Table 38. Americas 20s Proteasome Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas 20s Proteasome Revenue Market Share by Country (2017-2022)
Table 40. Americas 20s Proteasome Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas 20s Proteasome Sales Market Share by Type (2017-2022)
Table 42. Americas 20s Proteasome Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas 20s Proteasome Sales Market Share by Application (2017-2022)
Table 44. APAC 20s Proteasome Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC 20s Proteasome Sales Market Share by Region (2017-2022)
Table 46. APAC 20s Proteasome Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC 20s Proteasome Revenue Market Share by Region (2017-2022)
Table 48. APAC 20s Proteasome Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC 20s Proteasome Sales Market Share by Type (2017-2022)
Table 50. APAC 20s Proteasome Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC 20s Proteasome Sales Market Share by Application (2017-2022)
Table 52. Europe 20s Proteasome Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe 20s Proteasome Sales Market Share by Country (2017-2022)
Table 54. Europe 20s Proteasome Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe 20s Proteasome Revenue Market Share by Country (2017-2022)
Table 56. Europe 20s Proteasome Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe 20s Proteasome Sales Market Share by Type (2017-2022)
Table 58. Europe 20s Proteasome Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe 20s Proteasome Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa 20s Proteasome Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa 20s Proteasome Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa 20s Proteasome Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa 20s Proteasome Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa 20s Proteasome Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa 20s Proteasome Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa 20s Proteasome Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa 20s Proteasome Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of 20s Proteasome
Table 69. Key Market Challenges & Risks of 20s Proteasome
Table 70. Key Industry Trends of 20s Proteasome
Table 71. 20s Proteasome Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. 20s Proteasome Distributors List
Table 74. 20s Proteasome Customer List
Table 75. Global 20s Proteasome Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global 20s Proteasome Sales Market Forecast by Region
Table 77. Global 20s Proteasome Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global 20s Proteasome Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas 20s Proteasome Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas 20s Proteasome Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC 20s Proteasome Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC 20s Proteasome Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe 20s Proteasome Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe 20s Proteasome Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa 20s Proteasome Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa 20s Proteasome Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global 20s Proteasome Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global 20s Proteasome Sales Market Share Forecast by Type (2023-2028)
Table 89. Global 20s Proteasome Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global 20s Proteasome Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global 20s Proteasome Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global 20s Proteasome Sales Market Share Forecast by Application (2023-2028)
Table 93. Global 20s Proteasome Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global 20s Proteasome Revenue Market Share Forecast by Application (2023-2028)
Table 95. Amgen Inc Basic Information, 20s Proteasome Manufacturing Base, Sales Area and Its Competitors
Table 96. Amgen Inc 20s Proteasome Product Offered
Table 97. Amgen Inc 20s Proteasome Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Amgen Inc Main Business
Table 99. Amgen Inc Latest Developments
Table 100. Celgene Corp Basic Information, 20s Proteasome Manufacturing Base, Sales Area and Its Competitors
Table 101. Celgene Corp 20s Proteasome Product Offered
Table 102. Celgene Corp 20s Proteasome Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Celgene Corp Main Business
Table 104. Celgene Corp Latest Developments
List of Figures
Figure 1. Picture of 20s Proteasome
Figure 2. 20s Proteasome Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 20s Proteasome Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global 20s Proteasome Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. 20s Proteasome Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Marizomib
Figure 10. Product Picture of Oprozomib
Figure 11. Product Picture of Carfilzomib
Figure 12. Product Picture of VPEA-002
Figure 13. Product Picture of Others
Figure 14. Global 20s Proteasome Sales Market Share by Type in 2021
Figure 15. Global 20s Proteasome Revenue Market Share by Type (2017-2022)
Figure 16. 20s Proteasome Consumed in Colon Cancer
Figure 17. Global 20s Proteasome Market: Colon Cancer (2017-2022) & (K Pcs)
Figure 18. 20s Proteasome Consumed in Lymphoma
Figure 19. Global 20s Proteasome Market: Lymphoma (2017-2022) & (K Pcs)
Figure 20. 20s Proteasome Consumed in Malignant Glioma
Figure 21. Global 20s Proteasome Market: Malignant Glioma (2017-2022) & (K Pcs)
Figure 22. 20s Proteasome Consumed in Neuroendocrine Cancer
Figure 23. Global 20s Proteasome Market: Neuroendocrine Cancer (2017-2022) & (K Pcs)
Figure 24. 20s Proteasome Consumed in Ovarian Cancer
Figure 25. Global 20s Proteasome Market: Ovarian Cancer (2017-2022) & (K Pcs)
Figure 26. 20s Proteasome Consumed in Others
Figure 27. Global 20s Proteasome Market: Others (2017-2022) & (K Pcs)
Figure 28. Global 20s Proteasome Sales Market Share by Application (2017-2022)
Figure 29. Global 20s Proteasome Revenue Market Share by Application in 2021
Figure 30. 20s Proteasome Revenue Market by Company in 2021 ($ Million)
Figure 31. Global 20s Proteasome Revenue Market Share by Company in 2021
Figure 32. Global 20s Proteasome Sales Market Share by Geographic Region (2017-2022)
Figure 33. Global 20s Proteasome Revenue Market Share by Geographic Region in 2021
Figure 34. Global 20s Proteasome Sales Market Share by Region (2017-2022)
Figure 35. Global 20s Proteasome Revenue Market Share by Country/Region in 2021
Figure 36. Americas 20s Proteasome Sales 2017-2022 (K Pcs)
Figure 37. Americas 20s Proteasome Revenue 2017-2022 ($ Millions)
Figure 38. APAC 20s Proteasome Sales 2017-2022 (K Pcs)
Figure 39. APAC 20s Proteasome Revenue 2017-2022 ($ Millions)
Figure 40. Europe 20s Proteasome Sales 2017-2022 (K Pcs)
Figure 41. Europe 20s Proteasome Revenue 2017-2022 ($ Millions)
Figure 42. Middle East & Africa 20s Proteasome Sales 2017-2022 (K Pcs)
Figure 43. Middle East & Africa 20s Proteasome Revenue 2017-2022 ($ Millions)
Figure 44. Americas 20s Proteasome Sales Market Share by Country in 2021
Figure 45. Americas 20s Proteasome Revenue Market Share by Country in 2021
Figure 46. United States 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 47. Canada 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 48. Mexico 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 49. Brazil 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 50. APAC 20s Proteasome Sales Market Share by Region in 2021
Figure 51. APAC 20s Proteasome Revenue Market Share by Regions in 2021
Figure 52. China 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 53. Japan 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 54. South Korea 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 55. Southeast Asia 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 56. India 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 57. Australia 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 58. Europe 20s Proteasome Sales Market Share by Country in 2021
Figure 59. Europe 20s Proteasome Revenue Market Share by Country in 2021
Figure 60. Germany 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 61. France 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 62. UK 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 63. Italy 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 64. Russia 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 65. Middle East & Africa 20s Proteasome Sales Market Share by Country in 2021
Figure 66. Middle East & Africa 20s Proteasome Revenue Market Share by Country in 2021
Figure 67. Egypt 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 68. South Africa 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 69. Israel 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 70. Turkey 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 71. GCC Country 20s Proteasome Revenue Growth 2017-2022 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of 20s Proteasome in 2021
Figure 73. Manufacturing Process Analysis of 20s Proteasome
Figure 74. Industry Chain Structure of 20s Proteasome
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...